Vivimed Labs Limited (NSE:VIVIMEDLAB)

Market Cap	582.06M
Revenue (ttm)	1.09B
Net Income (ttm)	-243.69M
Shares Out	82.91M
EPS (ttm)	-2.94
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	633,456
Average Volume	474,911
Open	6.72
Previous Close	7.02
Day's Range	6.72 - 7.36
52-Week Range	6.92 - 29.40
Beta	0.97
RSI	2.46
Earnings Date	Feb 12, 2026

About Vivimed Labs

Vivimed Labs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, specialty chemicals, and retail branded formulations in India. It operates through two segments, Speciality Chemicals Business and Pharma Business. The company provides APIs and intermediates to generic and ethical companies; and branded formulations in therapeutic segments, such as ophthalmic, nutraceuticals, dermatology, and pain, as well as contract manufacturing of capsules and tablets, syrups ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1988
• Employees: 586
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: VIVIMEDLAB

Financial Performance

In 2024, Vivimed Labs's revenue was 1.21 billion, a decrease of -24.15% compared to the previous year's 1.59 billion. Losses were -319.61 million, -29.67% less than in 2023.